Clover Healths (CLOV) Gains 9.76% for August 5

Equities Staff  |

Shares of Clover Health Investments Corp - Class A (NASDAQ:CLOV) traded 9.76% higher on August 5 to close at $3.26.

10,371,228 traded hands. Their current average 30 day volume is 5,495,703 shares.

Clover Healths is down 20.16% year-to-date in 2022.

The company anticipates its next earnings on 2022-08-08.

For technical charts, analysis, and more on Clover Healths visit the company profile.

About Clover Health Investments Corp - Class A

Clover Health is a healthcare technology company with a deeply rooted mission of improving every life. Clover uses its proprietary technology platform to collect, structure, and analyze health and behavioral data to improve medical outcomes and lower costs for patients. As a company whose business goals fully align with its members' health needs, Clover works with members and their doctors to become a valued partner. This trust is built by proactively identifying at-risk individuals and teaming up with physicians to accelerate care coordination and simultaneously improve health outcomes and reduce avoidable costs. Clover has offices in San Francisco, Jersey City, Nashville and Hong Kong.

To get more information on Clover Health Investments Corp - Class A and to follow the company's latest updates, you can visit the company's profile page here: Clover Health Investments Corp - Class A's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Trending Articles

The Strong Dollar Is a Problem for Stocks
3 Ways Finance Teams Can Navigate Inflation Through Automation



Market Movers

Sponsored Financial Content